Treatment of Pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers

Details for Australian Patent Application No. 2009223092 (hide)

Owner Amicus Therapeutics, Inc

Inventors Do, Hung V.; Wustman, Brandon

Agent Wrays

Pub. Number AU-A-2009223092

PCT Pub. Number WO2009/114679

Priority 61/035,869 12.03.08 US

Filing date 12 March 2009

Wipo publication date 17 September 2009

International Classifications

A61K 38/47 (2006.01) Medicinal preparations containing peptides

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/114679 Priority application(s): WO2009/114679

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223108-Nanoparticulate compositions of angiogenesis inhibitors

2009223084-Inductive power supply system with multiple coil primary